BASF advances capabilities in infant nutrition with launch of 2'- fucosyllactose

Originally Published by BASF.

Newtrition, BASF’s human nutrition brand, will launch 2′-fucosyllactose (2′-FL), a human milk oligosaccharide (HMO) for the infant nutrition market by early 2019. HMOs are a unique group of carbohydrates naturally found in human breast milk with 2′-FL being the most abundant.


BASF has successfully mastered the complete in-house development of 2′-FL from strain to downstream processing using a specifically stable HMO fermentation strain designed for large-scale production. The German-based production provides the flexibility to enable high quality global roll-out that will consistently meet customer needs. BASF has received EU Novel Food approval for 2′-FL and is currently supporting regulatory clearance to facilitate access to other key markets.

Human milk is the gold standard for infant nutrition. When compared with infant formula, breastfeeding leads to favorable growth patterns, immune functions, cognitive development as well as positive long-term outcomes. For mothers who are unable to breastfeed, adding 2′-FL to infant milk formula is a substantial step in narrowing the functional gap between mother’s milk and breast milk substitutes.

Research findings suggest that 2′-fucosyllactose supports the development of a healthy gut microbiome and immune system, may protect against allergic diseases, and plays a role in the development of normal brain functions and cognition. Based on the ability to quench mucosal inflammation, 2′-FL is a promising ingredient for digestive health.

“The development of HMOs is a breakthrough in the nutritional improvement of infant formulas. 2′-fucosyllactose will open up new opportunities to strengthen a child’s health beginning with infancy and even beyond that,” said Franois Scheffler, Senior Vice President, BASF Human Nutrition. “Newtrition is committed to being at the scientific forefront of advancing nutrition and this launch is just the first step in the development of Newtrition’s HMO portfolio for infant nutrition initially and also dietary supplements in the near future.”

Newtrition, one of the market leaders in the human nutrition industry, offers a broad portfolio of essential nutrients including vitamins, carotenoids and high concentrate omega-3 fatty acids.

Latest News

Syracuse University campus

News Roundup: TV Diversity, Syracuse Hire, and Segregated Training

Check out our news roundup of diversity and inclusion updates and insights from across the U.S.: Syracuse University Creates Athletics Diversity Position  While most colleges and universities around the county are making COVID-19-related cuts in regard to their athletic departments, Syracuse University has hired Salatha T. Willis as the associate athletic…

Cesar Conde

NBCUniversal Sets Ambitious 50% Diversity Goal for Women, People of Color

Cesar Conde, chairman at NBCUniversal News Group, announced a groundbreaking goal to have a 50% diverse workforce at NBCUniversal, according to Deadline. Conde, the first Latino in this role, outlined his plans in an internal video for employees on Wednesday. The ultimate goal is for NBCUniversal, No. 7 on DiversityInc’s 2020…

Stop TB Partnership and Johnson & Johnson, with support from USAID and The Global Fund, Announce Price Reduction for SIRTURO® (bedaquiline) for Treatment of Drug-Resistant Tuberculosis in Low- and Middle-Income Countries

Originally published on jnj.com. Joint efforts aim to accelerate scale-up of WHO-recommended all-oral treatment regimens – a transition urgently needed to help protect the health of people with drug resistant-tuberculosis who are particularly vulnerable during COVID-19 pandemic In 2020, the initiative aims to reach at least 125,000 patients and could…

Toyota, Alabama A&M and Huntsville Hospital Collaborate to Make COVID-19 Testing Easier

Originally published on pressroom.toyota.com. $100,000 grant provides free service to the community Alabama A & M University (AAMU), Huntsville Hospital and Toyota are developing a mobile health clinic initiative to provide free COVID-19 testing to underserved communities in Madison County. Launching later this year, the mobile medical clinic program has…

Sanofi and Regeneron Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients

Originally published on sanofi.com. Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19 patients requiring mechanical ventilation did not meet its primary and key secondary endpoints when Kevzara was added to best supportive care compared to best supportive care alone (placebo)….

TD Bank: How a PPP Loan Saved Essential Jobs for Hundreds of Frontline Healthcare Heroes Amid COVID-19

Originally published on newscenter.td.com. Yet, “it’s not about earning a paycheck” for these medical responders A hero is defined as “a person who is admired or idealized for courage, outstanding achievements or noble qualities.” Never has that word resonated more than right now, with millions of frontline responders risking their…

Boeing Dreamlifter Transports 500,000 Protective Face Masks for Utah Students and Teachers

Originally published on boeing.mediaroom.com. Partnered with the state of Utah, Atlas Air, H.M. Cole, Cotopaxi, Flexport and UPS to deliver face masks to school districts with the greatest need Boeing [NYSE: BA] today completed its 12th COVID-19 transport mission, using a Boeing Dreamlifter to bring personal protective equipment (PPE) to the United…